Introduction
Human tuberculosis is a pandemic disease in many parts of the world causing approximately 2 million deaths annually. It is estimated that one-third of the world population is infected with Mycobacterium tuberculosis, the main cause of the disease (World Health OrganizationTuberculosis Fact Sheet Number 104). bacillus Calmette-Guérin (BCG) is the only approved vaccine against tuberculosis. It was developed through serial in vitro passages of Mycobacterium bovis until it was non-pathogenic. Although it has been effective against development of tuberculosis in some countries such as the United Kingdom [1] , its efficacy has been questioned in several other studies, most notably in India, where very limited protection has been reported [2] .
Even though BCG vaccine is safe and rarely induces disease in humans, BCG seems to mimic its own virulent strain and has the ability to inhibit antigen processing and presentation to T cells [3] [4] [5] . Macrophages infected with M. tuberculosis or BCG present low levels of major histocompatibility complex class II (MHC-II) [6, 7] ; this process is primarily dependent on IL-10 production induced by mycobacteria [8] . Corroborating with these studies, it was verified that dendritic cells exposed to BCG were able to induce naive T cell differentiation to IL-10 producer T cells. These observations indicate a possible contribution of BCG in preventing an immune response [9] , and promoting mycobacterial survival.
Reactive oxygen species (ROS) are produced by the NADPH oxidase system to combat invading microorganisms in host tissue [10] . Some pathogens can break the burst oxidative after their phagocytosis and evade the immune response. For example, the Francisella tularensis live vaccine strain was able to prevent the NADPH system assembly in human neutrophil phagosome, which permits its escape to cytosol and survival [11] . Like the F. tularensis vaccine, BCG and virulent mycobacterium strains can evade the immune system. BCG can prevent its death by inhibiting the phagosome-lysosome fusion acting on tryptophane aspartate-containing coat protein (TACO protein) in animal models or over its analogue protein, the coronin-1 in human leucocytes [12, 13] . Nevertheless, it is not known whether BCG has a direct effect on the NADPH oxidase system. Toll-like receptor 2 (TLR2) is involved in the recognition of mycobacteria and their purified components [4, 14] . The activation of TLR2 may trigger the expression of several genes through a complex signalization network [15] . Tuberculin PPD stimulation results in rapid activation of mitogen-activated protein kinases (MAPKs) and an early burst of ROS in monocytes ⁄ macrophages in a TLR2-dependent manner [16] . In addition, ROS are involved in modulating diverse receptor-ligand intracellular signalling pathways, including MAPK and nuclear factor-kB pathways [17] [18] [19] .
Given the lack of data about the possible effects of viable BCG vaccine on the NADPH oxidase system and the TLR2 leucocyte activation route, the aim of the present work was to investigate the NADPH activation and the gene expression of TLR2 in human peripheral blood mononuclear cell (PBMC). We also verified the IL-10 and TNF-a cytokine production and compared the two inactive BCG preparations, extended freeze-dried (EFD) and heat-killed (HK) BCG.
Materials and methods
Subjects. We collected blood samples from adult healthy donors (n = 50) (mean age, 26.2 years ± 6.8) for the PBMC assay. Informed consent was obtained from all participants, and the study was approved by Institute of Biomedical Sciences, University of Sao Paulo Ethics Committee, according to the Helsinki Convention.
BCG preparations. The HK and live BCG were obtained from Onco-BCG vaccine (Moreau strain, Copenhagen, seed # July 1978) developed by Butantan Institute (São Paulo, Brazil) [20] . The EFD BCG (Pasteur strain 1173P2) was prepared at Pasteur Institute (Paris, France) as previously described [21, 22] . The HK BCG was autoclaved for 30 min at 121°C in saline buffer. All bacilli were washed with saline buffer before their incubation with PBMC.
Cells and culture conditions. Venous blood samples were collected into heparinized tubes, and FicollHypaque (Sigma-Aldrich Histopaque Ò 1.077 g ⁄ ml; St. Louis, MO, USA) was used for PBMC cell separation. The PBMC were cultured in RPMI 1640 complete medium supplemented with 10% heat-inactivated foetal bovine serum and 2 mM L-glutamine at 37°C in a humidified 5% CO 2 atmosphere in 24-well plates, 5 · 10 5 cells ⁄ 500 ll ⁄ well for gene expression or 1 · 10 6 cells ⁄ ml ⁄ well for superoxide release or cytokine assays. The cells were incubated in the absence (control group) or presence of live, HK or EFD BCG (at an MOI of 20 BCG ⁄ PBMC), the TLR-2 ⁄ 6 ligand FSL-1 (synthetic diacylated lipopeptide FSL-1; Invivogen Ò , San Diego, CA, USA) (1 lg ⁄ ml), or IFN-c (100 U ⁄ ml) plus TNF-a (1000 U ⁄ ml) for 24 h. After incubation, 120 ll supernatant was collected from the respective culture wells and frozen at )80°C until cytokine analysis. The PBMC viability was measured by trypan blue method at the beginning and at the end of incubations.
Superoxide release. Superoxide release was assessed by a superoxide dismutase-inhibitable cytochrome c reduction assay, modified as previously described [23] . Briefly, PBMC cells (1 · 10 6 cells ⁄ ml ⁄ well) were cultured in 24-well plates for 24 h. On the day of the experiment, the plates were centrifuged, the supernatant removed, and the cells incubated in Hanks balanced salt solution (without phenol red) containing cytochrome c (50 lM) and phorbol myristate acetate (PMA; 300 nM) for 1 h at 37°C in a humidified 5% CO 2 atmosphere. Half of the wells received superoxide dismutase (50 U ⁄ ml) at the beginning of the incubation. PMA was used as an activator of superoxide release. After incubation, all plates were placed on ice, and the remaining wells received superoxide dismutase. The plates were centrifuged again, and the optical absorbance of the supernatants measured at 550 nm. The amount of superoxide released was calculated using an extinction coefficient of 0.021 ⁄ nM ⁄ cm. The results (nmol O 2 ) ⁄ 10 6 cells ⁄ h) were expressed by the difference of absorbance among samples that received or not SOD at the beginning of assay. At the end of the experiments, PBMC viability was assessed by trypan blue.
RT-PCR. Total RNA was isolated from PBMC (5 · 10 5 cells) by TRIzol (Invitrogen, Carlsbad, CA, USA), according to manufacturer's instructions. Reverse transcription of 1 lg total RNA was performed with SuperScript II RT and random hexamers. The cDNA was amplified for standard PCR using the kit QuantumRNA 18S Internal Standards (Applied Biosystems ⁄ Ambion, Austin, TX, USA) to normalize the amount of template. The following specific primers were used: gp91 phox (GenBank NM_000397.3): forward, 5¢-GCT CTA GAG CAT GAG GGG CTC TCC ATT TTT GTC A-3¢; reverse, 5¢-CGG GAT CCC GAG TTC AGA GAG TGC TAC TGA ATA A-3¢; p47 phox (GenBank NM_000265.4): forward, 5¢-GCG CTT CGT ACC CAG CCA GCA CTA TGT-3¢; reverse, 5¢-CTG TCG CGG TAC TCT TGC CAT CTT TGG C-3¢; and TLR2 (GenBank NM_003264.3): forward, 5¢-CCT GGG CAG TCT TGA ACA TT-3¢; reverse, 5¢-TTC CCA CTC TCA GGA TTT GC-3¢. Cycle conditions for the ABI 5700 thermal cycler were: 95°C for 2 min, followed by 30 cycles of denaturation at 95°C for 15 s, melting at 63°C for 30 s, extension at 72°C for 45 s and a long extension at 72°C for 7 min. The band densitometry of samples in agarose gel with ethidium bromide 1.5% was performed in Image-Master VDS System (Amersham Pharmacia ⁄ GE Healthcare Biosciences, Pittsburgh, PA, USA). The reactions were run in triplicate, and the results were represented as mean plus or minus SD.
Cytokine ELISA. Cytokine concentrations were analysed by ELISA, using IL-10 and TNF-a Duo Set kits (R&D Systems Inc., Minneapolis, MN, USA), according to the manufacturer's instructions. Optical density was determined using MR5000 ELISA reader (Thermolab Systems, Ashford, UK). Cytokine amounts were determined by standard curve comparison. The results were expressed in pg ⁄ ml ⁄ 10 6 PBMC. The PBMC number was carried out from blood cell counts on day 0.
Statistics
Results
To test the effect of live, HK, or EFD BCG or TLR-2 ⁄ 6 ligand FSL-1 on the NADPH oxidase system, we first studied the respiratory burst activity. As shown in Fig. 1 , the augment of superoxide release was observed only by PBMC samples incubated with rhIFN-c and rhTNF-a (P < 0.05), well-known NADPH oxidase activators [24] . Incubation of these cells with live BCG resulted in marked reduction in superoxide release (P < 0.05). In addition, a very significant difference between live and EFD BCG in superoxide induction was observed (P < 0.01). Live BCG was able to reduce in 69% the superoxide release induced by PMA. This activity was expressed by live viable PBMC as assessed by tripan blue count.
Investigating by which means the BCG had influenced the NADPH oxidase activity, we analysed the gene expression of CYBB and NCF1 which encode gp91 phox and p47
phox , respectively, the two principal subunits of this enzymatic system. As shown in Fig. 2A , live BCG decreased CYBB gene expression (P < 0.05). FSL-1 increases CYBB transcripts (P < 0.05); however, this was not associated with an increase in superoxide release. The NCF1 expression was not affected by the different BCG preparations or TLR-2 ⁄ 6 ligand FSL-1 (Panel B). IFN-c and TNF-a increased NCF1 expression (P < 0.05) and superoxide production; nevertheless, it did not augment the CYBB expression.
The TLR2 could trigger the expression of several genes in monocytes ⁄ macrophages and in polymorphonuclear cells through a complex signalization network [15] . It is generally involved in immunological responses to gram-positive bacteria [25, 26] . However, it is not known whether the increment in TLR2 expression could contribute to increase phagocyte activation against pathogen exposure.
We also explored the possibilities by which the BCG could interfere with the NADPH system by analysing the TLR2 gene expression of PBMC after incubation with different BCG preparations, and FSL-1. As shown in Fig. 2C , live BCG decreased the TLR2 gene expression (P < 0.01), without interfering with cell viability as assessed by tripan blue count.
It is well described in the literature that IL-10 has a potent anti-inflammatory effect, able to prevent phagocyte activation. BCG also inhibits the MHC class II molecule expression on the surface of phagocytes by inhibiting cathepsin S protein [6] , a mechanism that is IL-10 dependent [27] .
To explore the possible effects of live, HK, or EFD BCG, or FSL-1 on cytokine production by PBMC, we evaluated the IL-10 and TNF-a release after incubation protocols (Fig. 3) . Live and HK BCG markedly increased the TNF-a production (P < 0.001). On the other hand, the increasing effect of EFD BCG on this cytokine was 85% lower than that induced by HK BCG (P < 0.001) and 80% lower in relation to the live BCG effect (P < 0.001) (Panel A). The live, HK and EFD BCG increased IL-10 production (P < 0.001) (Panel B).
Discussion
The present work investigates the interaction between BCG and human leucocytes; our hypothesis states that there is an influence of live, HK or EFD BCG on the human NADPH oxidase system and also TLR2 gene expression as well as cytokine production using the human PBMC model. We observed that only live BCG inhibited superoxide release. These data corroborate with other studies where BCG and virulent strains of mycobacteria can evade the microbicidal mechanism of phagocytes. One mechanism of evasion is the inhibition of phagosome and lysosome fusion, involving TACO protein and its analogous coronin-1 in human leucocytes [12, 13] . These results are particularly interesting once, Bustamante et al., our group included [28] have recently identified mutations on CYBB that are associated with mendelian susceptibility to mycobacterial disease (MSMD), demonstrating that the respiratory burst in human macrophages is a crucial mechanism against tuberculous mycobacteria.
In vitro research showed that BCG is able to increase the TLR2 gene expression in human uroepithelial and bladder cancer cells [29] [30] [31] [32] . Some studies demonstrate that TLR2 activation by bacterial lipoproteins can activate nuclear factor kappa jB (NF-jB) and initiate the production of reactive oxygen intermediates by the THP-1 lineage [33, 34] .
One recent work of our group showed that CYBB and NCF1 gene expression and the consequent superoxide release are dependent on NF-jB action [35] . It is well known that TLR2 participates on NF-jB activation pathway and that BCG wall contains diverse lipoproteins that are able to bind it [36] .
We verified that live BCG was able to inhibit the TLR2 expression, while inactivated HK and EFD BCG and FSL-1 did not. These results together with the increasing on CYBB gene expression by PBMC because of the FSL-1 stimulus corroborate with the findings of Luengo-Blanco et al. [35] . It is likely that inhibition of TLR2 gene expression by live BCG decreases the availability of this receptor on PBMC membrane surface leading to impairment of NF-jB activation, contributing to lower gene expression of CYBB and NCF1 which was followed by a reduction in NADPH oxidase activity measured by superoxide release.
Live BCG was capable to stimulate TNF-a and IL-10 cytokine production. The elevated levels of IL-10 showed in our results could contribute to the inhibitory effects on the NADPH oxidase and TLR2 gene expression, demonstrating that this cytokine can down regulate signalling activation. Simas et al. [37] reported similar results about TNF-a cytokine production by live BCG. Noteworthy, we did not observe any significant difference in cell-death patterns among our studied groups.
The levels of TNF-a and IL-10 in the supernatant of PBMC exposed to HK BCG were similar to those stimulated by live BCG, demonstrating that the BCG heat killing process can alter the inhibitory effect of BCG over the NADPH oxidase and TLR2 gene expression, however, without alteration of its capacity to induce cytokines production.
Studies based on animal models have demonstrated that EFD BCG is able to control and in some cases reverse allergic inflammation, for example, decreasing eosinophilia, preventing bronchial hyperreactivity and the increase in fibronectin in airway lumen, confirming the anti-inflammatory properties of the preparation [21, 22] . Our results corroborate with those obtained about EFD BCG from murine models of asthma and are presented here for the first time in human PBMC. This preparation does not affect the NADPH oxidase system neither the TLR2 gene expression on human PBMC. Moreover, PBMC incubated with EFD BCG had augmented IL-10 and did not show alteration of TNF-a production. This pattern of effects could be interesting in asthma treatment potentially favouring the control of inflammation in asthmatic lungs.
The inhibition of NADPH oxidase activation at a gene expression level, the decrease in TLR2 gene expression as well the great production of IL-10 induced by viable BCG showed in our results, may represent novel mechanisms by which live BCG can jeopardize its demise and evade the human immunological system. This is the first work to illustrate that live and different inactivate forms of BCG induce diverse responses on NADPH oxidase system activation, TLR2 gene expression and IL-10 cytokine production by human leucocytes in vitro.
Future work investigating signalling pathways and other BCG strains is necessary to clarify our understanding on how live and inactivate BCG preparations exert their influences. Studies involving live or HK BCG Pasteur strain 1173P2 and EFD BCG Moreau strain will also be important.
